Udenyca: payments to doctors
Payments that named Udenyca as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $798K
- Providers
- 4,045
- Transactions
- 9,950
- Average per transaction
- $80
The per-transaction average — $80 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 4,045 providers the average total is $197, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Coherus Biosciences Inc. | $776,335 | 97.3% |
| Accord Healthcare, Inc. | $15,970 | 2.0% |
| Coherus Oncology, Inc. | $5,580 | 0.7% |